This content is only available via PDF.
Skip Nav Destination
Article navigation
Editorial Views|
February 1979
Rationale for Dantrolene vs.Procainamide for Treatment of Malignant Hyperthermia
Anesthesiology February 1979, Vol. 50, 118–122.
Citation
Thomas E. Nelson, Eugene H. Flewellen; Rationale for Dantrolene vs.Procainamide for Treatment of Malignant Hyperthermia . Anesthesiology 1979; 50:118–122 doi: https://doi.org/10.1097/00000542-197902000-00008
Download citation file:
Citing articles via
Most Viewed
Related Articles
Cost-effectiveness Analysis of Stocking Dantrolene in Ambulatory Surgery Centers for the Treatment of Malignant Hyperthermia
Anesthesiology (June 2014)
Succinylcholine Use and Dantrolene Availability for Malignant Hyperthermia Treatment: Database Analyses and Systematic Review
Anesthesiology (January 2019)
Cost-benefit Analysis of Maintaining a Fully Stocked Malignant Hyperthermia Cart versus an Initial Dantrolene Treatment Dose for Maternity Units
Anesthesiology (August 2018)
Intramuscular Injection of Sevoflurane Detects Malignant Hyperthermia Predisposition in Susceptible Pigs
Anesthesiology (October 2007)
Induction of Malignant Hyperthermia in Susceptible Swine by 3,4-Methylenedioxymethamphetamine (“Ecstasy”)
Anesthesiology (November 2003)